ArticleJournal of clinical medicine2026
Towards New Strategies: Case Report and Review of the Literature-Effective Use of JAK Inhibitor Baricitinib in a 4-Year-Old Boy with Anti-MDA5 Antibody-Positive Juvenile Dermatomyositis.
Oana Buzoianu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.